Addison Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$51K Sell
1,059
-114
-10% -$5.32K 0.01% 419
2025
Q4
$56.8K Buy
1,173
+82
+8% +$4.07K 0.01% 404
2025
Q3
$51.5K Sell
1,091
-190
-15% -$9.17K 0.01% 416
2025
Q2
$61.9K Sell
1,281
-9
-0.7% -$460 0.02% 383
2025
Q1
$71.5K Buy
1,290
+44
+4% +$2.38K 0.02% 341
2024
Q4
$60.1K Sell
1,246
-65
-5% -$3.31K 0.02% 363
2024
Q3
$75.6K Buy
1,311
+237
+22% +$12.8K 0.02% 337
2024
Q2
$52.1K Buy
1,074
+71
+7% +$3.42K 0.02% 372
2024
Q1
$48.7K Buy
1,003
+71
+8% +$3.47K 0.02% 371
2023
Q4
$46.3K Buy
932
+159
+21% +$7.78K 0.02% 363
2023
Q3
$41.5K Buy
773
+312
+68% +$16.6K 0.02% 349
2023
Q2
$24.8K Sell
461
-15
-3% -$807 0.01% 391
2023
Q1
$25.9K Sell
476
-46
-9% -$2.24K 0.01% 364
2022
Q4
$25.3K Sell
522
-322
-38% -$14.1K 0.02% 349
2022
Q3
$32K Sell
844
-763
-47% -$34K 0.02% 308
2022
Q2
$80K Sell
1,607
-266
-14% -$14.1K 0.05% 213
2022
Q1
$96K Buy
1,873
+905
+93% +$46.7K 0.05% 209
2021
Q4
$48K Buy
968
+950
+5,278% +$47K 0.03% 252
2021
Q3
$1K Buy
+18
New +$915 ﹤0.01% 429

Other funds holding SNY

Addison Advisors's SNY Position: Q1 2026 in Review

Addison Advisors reduced its Sanofi (SNY) stake by 9.7% in Q1 2026, selling an estimated $5.32K and leaving 1,059 shares worth $51K. The position accounts for 0.01% of the portfolio, ranked #419.

Addison Advisors first reported a position in SNY in Q3 2021 and has held it in 19 quarters since. The position peaked at $96K in Q1 2022. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Addison Advisors held 1,059 shares of Sanofi worth $51K as of Q1 2026.
  • Addison Advisors sold 114 Sanofi shares in Q1 2026, an estimated $5.32K.
  • Sanofi made up 0.01% of Addison Advisors's portfolio in Q1 2026, its #419 holding.
  • Addison Advisors first reported a position in Sanofi in Q3 2021 and has held it in 19 quarters since.
  • Addison Advisors's Sanofi position peaked at $96K in Q1 2022.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Addison Advisors's 13F filing for Q1 2026, filed 8 May 2026.